Senate Passes $190 Million Pediatric Cancer Research Bill, H.R.3391, After House Approval on March 5, 2024, by 384-4 Vote

Dec 20, 2024, 08:40 PM

A $190 million funding bill for pediatric cancer research, known as the Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-controlled House on March 5, 2024, with an overwhelming vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, where Senate Majority Leader Chuck Schumer has not brought it up for a vote. This situation has led to accusations against Democrats for allegedly using the funding as a bargaining chip in broader negotiations. Recently, the Senate passed the bill unanimously, allowing it to move to President Biden for final approval. The bill's passage comes after a period of intense political discourse, where Democrats were criticized for blaming Republicans for the funding's delay, despite the bill's prior approval in the House.